1. MARKETS
  2. SECTOR : PHARMACEUTICALS & BIOTECHNOLOGY
  3. INDUSTRY : PHARMACEUTICALS
  4. ACCENT MICROCELL LTD.
Accent Microcell Ltd.
NSE: ACCENTMIC

Accent Microcell Live Share Price Today, Share Analysis and Chart

aboutAccent Microcell Ltd. is an India-based manufacturer specializing in cellulose-based excipients, primarily Microcrystalline Cellulose (MCC). The company serves diverse industries including pharmaceuticals, nutraceuticals, food and beverages, and ... Read More
Ask AI about Accent Microcell
639.005.00(0.79%)
15,000
NSE Volume

NSE 30 Oct, 2026 3:31 PM (IST)

Portfolio

Alert

My Notes

Accent Microcell Stock Price Analysis

Day Price Range

0.8% 1 Day return
639 (LTP)
630649
LowHigh

Week Price Range

7.8% 1 Week return
639 (LTP)
580.6700
LowHigh

Month Price Range

-5.3% 1 Month return
639 (LTP)
560700
LowHigh

52 Week Price Range

132.1% 1 Year return
639 (LTP)
273731.7
LowHigh

Accent Microcell Technical Analysis

Accent Microcell EMA & SMA

Neutral0
4 bullish, 4 bearish
Bullish4
Bearish4
5 Day635.4
10 Day640.0
12 Day642.0
20 Day647.1
26 Day647.4
50 Day632.0
100 Day583.4
200 Day506.6

Accent Microcell Delivery And Volume

Daily Avg. Delivery Volume %
30 Oct, 202653.3%
Week62.8%
Month66.2%
Legend
Positive IndicatorNeutral IndicatorNegative Indicator

Accent Microcell Resistance and Support

639.35
Pivot
First Resistance648.7
Second Resistance658.3
Third Resistance667.6
First Support629.7
Second Support620.4
Third Support610.8
Day RSI48
Day MACD-5.3
Day MFI63
Day MACD Signal Line-1

Accent Microcell Beta

1 Month1.4
1 Year0.7
3 Month0.7
3 Year-

Accent Microcell Price Change Analysis

↓-5.3%
Over 1 Month
LowHigh
560700
↑25.8%
Over 3 Months
LowHigh
492.1731.7
↑50.2%
Over 6 Months
LowHigh
411731.7
↑132.1%
Over 1 Year
LowHigh
273731.7

Accent Microcell Shareholding Pattern/ Ownership

Shareholding Summary

Sep 2026
 
NameCategorySharesShares %
Nitin Jasvantbhai PatelPromoter3,769,60015.7 %
Kantilal Pachan VadiaPublic1,953,1708.1 %
Negen Undiscovered Value FundDii289,7901.2 %

HISTORICAL PROMOTER HOLDING

HISTORICAL FII HOLDING

HISTORICAL MF HOLDING

Accent Microcell Deals - Insider, Bulk, Block and SAST

Client NameDeal TypeActionDateAvg. PriceQuantityExchange
GHANSHYAM ARJANBHAI PATELBulkSell20 Jul 2026521.01390,000NSE
GHANSHYAM ARJANBHAI PATELBulkSell09 Jun 2026476.95586,000NSE
KAMLESH B AMIN HUFBulkPurchase09 Jun 2026475125,000NSE
HIMANSHU B. AMIN (HUF)BulkPurchase09 Jun 2026479.66125,000NSE
MANOJ AGARWAL HUFBulkPurchase23 Dec 2024277.20150,000NSE
MERU INVESTMENT FUND PCC- CELL 1BulkSell16 Jan 2024303.01240,000NSE
MANOJ AGARWALBulkPurchase15 Dec 2023298.86120,000NSE

Accent Microcell Corporate Actions

Accent Microcell Dividend history and yield

Accent Microcell dividend yields, including actual and adjusted, and dividend history, including announcement, record, and ex-dividend dates. Track Accent Microcell dividend yield over time.

#Ex-Date
Dividend AmountDividend TypeRecord DateInstrument Type
117 Jul 2026
1FINAL17 Jul 2026Equity Share
216 Sep 2025
1FINAL16 Sep 2025Equity Share

Accent Microcell Board Meetings

Accent Microcell past and upcoming board meetings.

#Ex-Date
PurposeNotes
112 May 2026
Audited Results, Dividend & OthersTo consider other business matters.
214 Oct 2025
Quarterly Results & OthersTo consider other business matters.
322 Aug 2025
Dividend & OthersTo consider other business matters.
429 May 2025
To Consider Fund Raising & OtherTo consider other business matters.
509 May 2025
Audited Results & OthersTo consider other business matters.

Accent Microcell Rights issue

Accent Microcell rights issue history, along with record, ex-rights dates, and rights ratios.

#Ex-Date
RatioFace ValuePremiumRecord Date
104 Jun 2025
7.0:50.01012504 Jun 2025

Accent Microcell DocumentsAsk MarketMind AI

Accent Microcell Credit Ratings

Accent Microcell credit ratings from CRISIL and leading rating agencies, assessing financial stability, investment grade, and related PDF documentation.

DateRating AgencyCompany NameDescriptionLinks
21 Oct 2026crisil ratingsAccent Microcell LimitedAccent Microcell Limited:Issuer not cooperating, based on best-available information; Ratings revised to 'Crisil BB-/Stable/Crisil A4+ Issuer not cooperating\u2019
24 Mar 2026care ratingsAccent Microcell Limited
26 Feb 2026crisil ratingsAccent Microcell LimitedAccent Microcell Limited:Issuer not cooperating, based on best-available information; Ratings revised to \u2018Crisil B/Stable/Crisil A4 Issuer not cooperating\u2019
19 Mar 2025care ratingsAccent Microcell Limited
26 Dec 2024crisil ratingsAccent Microcell LimitedAccent Microcell Limited:Issuer not cooperating, based on best-available information; Ratings continues to be \u2018CRISIL B+/Stable/CRISIL A4 Issuer not cooperating'

Accent Microcell - Company Profile

Accent Microcell Management Structure

Accent Microcell management structure with salaries, total experience, and qualifications.

NAMEDESIGNATIONGROSS REMUNERATION ₹(LAC)AS OFHISTORY & DETAILS
Mr. Ghanshyam PatelManaging Director,Chief Financial Officer-Mar 26
Hiral Kanubhai GediyaCompany Secretary,Compliance Officer-Mar 26

Accent Microcell Board of Directors

Accent Microcell Board of directors with salaries, total experience, and qualifications.

NAMEPOSITIONGROSS REMUNERATION ₹(LAC)AS OFHISTORY & DETAILS
Vasant Vadilal PatelChairman / Executive Director / WTD-Mar 26
Ghanshyam Arjanbhai PatelManaging Director & CFO-Mar 26
Nitin Jasvantbhai PatelE D & Wholetime Director-Mar 26
Vinodbhai Manibhai PatelE D & Wholetime Director-Mar 26
Rajatkumar Dineshbhai patelIndependent Non Exe. Director-Mar 26
Shreya M ShahIndependent Non Exe. Director-Mar 26
Hiral Kanubhai GediyaCompany Sec. & Compli. Officer-Mar 26
Pooja Dharmesh ShahIndependent Non Exe. Director-Mar 26

About the company - Business Profile

Accent Microcell Ltd. is an India-based manufacturer specializing in cellulose-based excipients, primarily Microcrystalline Cellulose (MCC). The company serves diverse industries including pharmaceuticals, nutraceuticals, food and beverages, and cosmetics. Accent Microcell has established a significant presence in both domestic and international markets, exporting to over 45 countries, including the USA, Canada, Germany, and the UK.

Key Points

Key Facts

  • Founded Year: 2001 (Incorporated as a private limited company).
  • Headquarters: Ahmedabad, Gujarat, India.
  • Stock Listing: Listed on the NSE SME platform (Emerge) following its Initial Public Offering in December 2023.
  • Primary Products: Microcrystalline Cellulose (MCC), Carboxymethyl Cellulose (CMC), Croscarmellose Sodium (CCS), and other excipients.

Operations and Resources

  • Manufacturing Facilities: The company operates two state-of-the-art manufacturing units:
    • Unit I: Located in Pirana Road, Ahmedabad.
    • Unit II: Located in Dahej SEZ, Bharuch, Gujarat.
  • Integration: The Dahej facility is a 100% Export Oriented Unit (EOU), strategically located to serve international clients efficiently.
  • Capacity: As of recent filings, the company has an aggregate manufacturing capacity of approximately 8,000 metric tonnes per annum (MTPA).

Market and Significance

  • Industries Served: Predominantly pharmaceutical (tablets/capsules formulation), food (stabilizers), and cosmetics (texturizers).
  • Strategic Importance: It is one of the leading manufacturers of MCC in India, competing with major players like Sigachi Industries. The company provides more than 20 grades of MCC, tailored for specific moisture levels and particle sizes.

Business Model and Strengths

  • Model: Focuses on high-quality production of specialized excipients that act as binders and disintegrants in drug manufacturing.
  • Strengths: Extensive product range (MCC grades 101, 102, 112, etc.), a robust global distribution network, and adherence to international quality standards (USP, BP, EP, and JP).

Revenue Breakdown (FY 2023-24)

  • Total Revenue from Operations: ₹247.33 crore.
  • Net Profit: ₹30.34 crore.
  • Geographical Breakdown:
    • Exports: Historically contributes approximately 70% - 75% of total revenue.
    • Domestic: Contributes the remaining 25% - 30%.

Innovation and Future Outlook

  • Strategic Initiatives: Utilizing IPO proceeds for setting up a new plant at Navagam, Kheda, to manufacture Croscarmellose Sodium (CCS) and Sodium Starch Glycolate, further diversifying its excipient portfolio.
  • Innovation: Continuous development of "Ready-to-use" co-processed excipients to simplify drug manufacturing processes for pharmaceutical clients.

Employee and Human Resources

  • Employee Count: Approximately 200+ employees across manufacturing and corporate functions.

References

  1. Annual Report Mar 2025
  2. Investor Presentation Oct 2025
  3. Earnings Call Feb 2026

Accent Microcell FAQ

Accent Microcell today is trading in the green, up by 0.79% at ₹639.
Accent Microcell is currently trading up 0.79% on an intraday basis. In the past week the stock rose 7.85%. Stock has been up 25.76% in the past quarter and rose 132.11% in the past year. You can view this in the share price history/seasonality section.
Accent Microcell is listed on NSE with the ticker ACCENTMIC. It's currently trading on NSE at a share price of ₹639.
The market cap of Accent Microcell is ₹1,532.9 Cr. as of Oct 30, 2026.
Accent Microcell announced a FINAL dividend of 10% which equals ₹1 in Jul 17, 2026.The last ex-date for Accent Microcell was Sep 16, 2025. To view the full dividend history of Accent Microcell click here.
Accent Microcell has never issued stock splits or bonus shares since the time of its listing on the NSE exchange.
Accent Microcell reported ₹355.8 Cr. in revenue, ₹43.86 Cr. in net profit, and ₹63.46 Cr. in EBITD as of Mar 31, 2026 for FY25-26.
There are no analyst predictions for stock price target for Accent Microcell.
The PE ratio of Accent Microcell is 34.95 as of Oct 30, 2026.
The PB ratio of Accent Microcell is 5.56 as of Oct 30, 2026.
There are no analyst reports for Accent Microcell.
You can set real-time stock alerts on price, volume, SMA, and several other parameters by scrolling to the top of this page and clicking the bell icon on the far right-hand side of the stock overview.